Journal Information

Most cited

29
JAK-STAT pathway inhibitors in dermatology
Hélio Amante Miot, Paulo Ricardo Criado, Caio César Silva de Castro, Mayra Ianhez, Carolina Talhari, Paulo Müller Ramos
29
Full text access
14
COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation
Alba Navarro-Bielsa, Tamara Gracia-Cazaña, Beatriz Aldea-Manrique, Isabel Abadías-Granado, Adrián Ballano, Isabel Bernad, Yolanda Gilaberte
14
Full text access
13
Female-pattern hair loss: therapeutic update
Paulo Müller Ramos, Daniel Fernandes Melo, Henrique Radwanski, Rita Fernanda Cortez de Almeida, Hélio Amante Miot
13
Full text access
11
Inhibition of ANGPT2 activates autophagy during hypertrophic scar formation via PI3K/AKT/mTOR pathway
Hongxin Chen, Kai Xu, Chao Sun, Si Gui, Juanjuan Wu, Song Wang
11
Full text access
10
Merkel cell carcinoma: epidemiology, clinical features, diagnosis and treatment of a rare disease
Stella Oliveira Meireles Siqueira, Gabriella Campos-do-Carmo, Alexssandra Lima Siqueira dos Santos, Cícero Martins, Andreia Cristina de Melo
10
Full text access
9
Comedogenic lupus: a rare variant of chronic cutaneous lupus erythematosus – case series
Lucas Campos Garcia, Isabela Boechat Morato, Raquel Ferreira Queiroz de Melo, Everton Carlos Siviero do Vale
9
Open access
8
Chemotherapeutical treatment of basal cell carcinoma with bleomycin via microinfusion of the drug into the skin (MMP®)
Paulo Rodrigo Pacola, Renato Roberto Liberato Rostey, Fernanda de Figueiredo Arruda Rizzo
8
Full text access
Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.